Protagenic Therapeutics(PTIX) - 2022 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission File Number: 001-12555 PROTAGENIC THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 06-1390025 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 149 Fifth Avenue, Suite 500, New York, New York 10010 (Address of Principal Executive Office) (Zip Code) (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchan ...